Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.4.1 extracted from

  • Gautam, L.K.; Sharma, P.; Capalash, N.
    Bacterial polyphosphate kinases revisited role in pathogenesis and therapeutic potential (2019), Curr. Drug Targets, 20, 292-301 .
    View publication on PubMed

Organism

Organism UniProt Comment Textmining
Bacillus cereus
-
-
-
Escherichia coli
-
-
-
Escherichia coli K1 (RS218)
-
-
-
Francisella tularensis
-
-
-
Helicobacter pylori
-
-
-
Neisseria meningitidis
-
-
-
Porphyromonas gingivalis
-
-
-
Proteus mirabilis
-
-
-
Pseudomonas aeruginosa
-
-
-
Salmonella enterica subsp. enterica serovar Typhimurium
-
-
-

Synonyms

Synonyms Comment Organism
PPK
-
Salmonella enterica subsp. enterica serovar Typhimurium
PPK
-
Proteus mirabilis
PPK
-
Porphyromonas gingivalis
PPK1
-
Escherichia coli
PPK1
-
Pseudomonas aeruginosa
PPK1
-
Neisseria meningitidis
PPK1
-
Helicobacter pylori
PPK2
-
Pseudomonas aeruginosa
PPK2
-
Francisella tularensis

General Information

General Information Comment Organism
drug target the absence of a polyphosphate kinase orthologue in humans makes it a potential drug target Salmonella enterica subsp. enterica serovar Typhimurium
drug target the absence of a polyphosphate kinase orthologue in humans makes it a potential drug target Escherichia coli
drug target the absence of a polyphosphate kinase orthologue in humans makes it a potential drug target Pseudomonas aeruginosa
drug target the absence of a polyphosphate kinase orthologue in humans makes it a potential drug target Neisseria meningitidis
drug target the absence of a polyphosphate kinase orthologue in humans makes it a potential drug target Bacillus cereus
drug target the absence of a polyphosphate kinase orthologue in humans makes it a potential drug target Proteus mirabilis
drug target the absence of a polyphosphate kinase orthologue in humans makes it a potential drug target Helicobacter pylori
drug target the absence of a polyphosphate kinase orthologue in humans makes it a potential drug target Porphyromonas gingivalis
drug target the absence of a polyphosphate kinase orthologue in humans makes it a potential drug target Francisella tularensis
malfunction polyphosphate kinase deletion causes decreased resistance to oxidative, heat and hyperosmotic stress, attenuated swarming and biofilm formation, increased production of prolyl isomerase, phosphotransferase and peptidoglycan synthase repressor proteins Proteus mirabilis
malfunction polyphosphate kinase deletion causes decreased virulence and low invasiveness Salmonella enterica subsp. enterica serovar Typhimurium
malfunction polyphosphate kinase deletion causes loss of biofilm formation on polyvinyl chloride (PVC) or borosilicate Porphyromonas gingivalis
malfunction polyphosphate kinase deletion decreases sporulation, motility and biofilm formation Bacillus cereus
malfunction polyphosphate kinase deletion increases sensitivity to H2O2 and reduces polyphosphate accumulation. Polyphosphate kinase deletion upregulates fermentation, aerobic and anaerobic respiration, enhances catalase and Clp protease activity, down-regulates ATP-dependent RNA helicase, DNA polymerase III and pyruvate kinase I Escherichia coli
malfunction polyphosphate kinase ppk1 deletion causes loss of virulence and biofilm formation, impaired motility and increased susceptibility to antibiotics. Polyphosphate kinase ppk2 deletion causes increased susceptibility to antibiotics Pseudomonas aeruginosa
malfunction polyphosphate kinase ppk1 deletion causes low polyphosphate accumulation, loss of virulence, reduced colonization in mice and decreased motility Helicobacter pylori
malfunction polyphosphate kinase ppk1 deletion causes poor survival during osmotic shock and acid challenge Escherichia coli
malfunction polyphosphate kinase ppk1 deletion increases serum sensitivity Neisseria meningitidis
malfunction polyphosphate kinase ppk2 deletion causes increased sensitivity to antibiotics Francisella tularensis
physiological function the enzyme has wide distribution among pathogens and is involved in promoting pathogenesis, stress management and susceptibility to antibiotics Salmonella enterica subsp. enterica serovar Typhimurium
physiological function the enzyme has wide distribution among pathogens and is involved in promoting pathogenesis, stress management and susceptibility to antibiotics Escherichia coli
physiological function the enzyme has wide distribution among pathogens and is involved in promoting pathogenesis, stress management and susceptibility to antibiotics Pseudomonas aeruginosa
physiological function the enzyme has wide distribution among pathogens and is involved in promoting pathogenesis, stress management and susceptibility to antibiotics Neisseria meningitidis
physiological function the enzyme has wide distribution among pathogens and is involved in promoting pathogenesis, stress management and susceptibility to antibiotics Bacillus cereus
physiological function the enzyme has wide distribution among pathogens and is involved in promoting pathogenesis, stress management and susceptibility to antibiotics Proteus mirabilis
physiological function the enzyme has wide distribution among pathogens and is involved in promoting pathogenesis, stress management and susceptibility to antibiotics Helicobacter pylori
physiological function the enzyme has wide distribution among pathogens and is involved in promoting pathogenesis, stress management and susceptibility to antibiotics Porphyromonas gingivalis
physiological function the enzyme has wide distribution among pathogens and is involved in promoting pathogenesis, stress management and susceptibility to antibiotics Francisella tularensis